Evidence-based perspectives on Mesenchymal Stem Cell therapy, regenerative medicine, and the technologies redefining how we age — curated by the VELAR clinical team.
From ethically sourced Wharton's jelly to Certificate of Analysis release — walk through every stage of how clinical-grade Mesenchymal Stem Cells are cultivated, verified, and prepared for therapy.
Read the full story →
MSC anti-inflammatory action, paracrine lung-repair signaling and the Phase II remestemcel-L trial — the mechanisms, the FEV1/6MWT outcomes, and an honest look at what is still investigational.
Allogeneic umbilical-cord MSC immunomodulation, regulatory T-cell modulation and the Nanjing transplantation trials — lupus nephritis outcomes, SLEDAI scoring, and the honest limitations.
HSCT, MSC immunomodulation and the MIST trial — what the research actually shows for relapsing and progressive MS, and the honest limitations.
Neural stem cells, OPCs and the SCiStar trial — the mechanisms, the ASIA-scale outcomes, and a responsible look at what is still investigational.
How MSC exosomes carry the regenerative signal of stem cells without the cells themselves — the science, the research status, and the honest limitations.
A careful, evidence-based review of where MSC therapy fits — and the responsible boundaries of family expectations.
How MSC therapy supports follicular regeneration in androgenetic alopecia, alopecia areata, and other forms of hair loss.
Where MSC therapy realistically fits in diabetes management — alongside diet, exercise, and standard endocrine care.
MSCs in neurodegenerative care — neuroinflammation, mitochondrial support, alongside standard neurology.
What MSC therapy can — and cannot — do for motor neuron disease. A patient-focused clinical review.
How MSC therapy may support stroke recovery — calming neuroinflammation, protecting at-risk neurons, supporting repair pathways.
What shapes price, the certifications that matter, and the questions every international patient should ask before booking regenerative medicine.
How MSC therapy modulates the immune system in rheumatoid arthritis, lupus, multiple sclerosis, and other autoimmune disease — without broad immunosuppression.
How MSC therapy targets cellular senescence, mitochondrial decline, and chronic inflammation to influence the underlying drivers of how we age.
How MSC therapy supports cartilage regeneration, reduces joint inflammation, and helps patients regain mobility — with realistic timelines and what to expect.
Compare bone marrow, adipose, and umbilical cord MSC sources — and discover why Wharton's jelly has become the gold standard for clinical-grade therapy.
An evidence-based introduction to MSC therapy — what it is, how it works, who it helps, and what the latest clinical research shows.